Inventor · Solana Beach, CA, US

Brian Lannutti

17Patents
3h-index
20Co-inventors
56Inventor score

Filing activity: Apr 20, 2010 → Aug 16, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10272083B2 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Chemistry; Metallurgy 8 Active
US10335496B2 ROR1 antibody immunoconjugates Chemistry; Metallurgy 7 Active
US10159660B2 Uses of indolinone compounds Chemistry; Metallurgy 3 Active
US11771696B2 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Chemistry; Metallurgy 3 Active
US9949971B2 Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor Chemistry; Metallurgy 3 Active
US11654143B2 Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor Human Necessities 2 Active
US10646470B2 Uses of indolinone compounds Chemistry; Metallurgy 2 Active
US11090302B2 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Chemistry; Metallurgy 2 Active
US10328080B2 Therapeutic combination of PI3K inhibitor and a BTK inhibitor Human Necessities 2 Active
US11166951B2 Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor Human Necessities 1 Active
US9492449B2 Therapies for hematologic malignancies Human Necessities 1 Active
US11285132B2 Uses of indolinone compounds Chemistry; Metallurgy 1 Active
US12161626B2 Uses of indolinone compounds Chemistry; Metallurgy 0 Active
US10154998B2 Therapies for hematologic malignancies Human Necessities 0 Active
US8546409B2 Methods of treatment for solid tumors Human Necessities 0 Active
US11154554B2 Therapeutic combinations of a MEK inhibitor and a BTK inhibitor Human Necessities 0 Active
US12263164B2 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.